ArticleMicrobial genomics2021
Alterations in chromosomal genes
Open access · goldAbstract read
In one paragraph
Article in Microbial genomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 32 citations in OpenAlex.
- Exploring the in situ evolution of nitrofurantoin resistance in clinically derived uropathogenic Escherichia coli isolates.The Journal of antimicrobial chemotherapy · 2023Trial
- UropathogenicAntibiotics (Basel, Switzerland) · 2026Review
- Nitrofurantoin treatment and prophylaxis for recurrent urinary tract infections in women: First-line for a reason.PLoS pathogens · 2026Review
- Selective Reprogramming of Ribosome Assembly and Translational Control during Bacterial Growth Phase Transitions.ACS omega · 2026Article
- Covalent Inhibitors in Antimicrobial Drug Development-Beyond β-Lactams.Molecules (Basel, Switzerland) · 2026Review
- Antimicrobial resistance and virulence of Enterococcus faecium isolates from a traditionally fermented dairy beverage from Uganda.BMC microbiology · 2026Article
- Characterization of nitroreductase gene A ofOpen life sciences · 2026Article
- Molecular mechanisms of antibiotic resistance in Gram-positive and Gram-negative bacteria - a narrative review.Frontiers in cellular and infection microbiology · 2026Review
- Poultry-associated nitrofurantoin-resistant and pre-resistantOne health (Amsterdam, Netherlands) · 2025Article
- Nitrofurantoin resistance mechanisms in uropathogenic Escherichia coli isolates from Iran.Annals of clinical microbiology and antimicrobials · 2025Article
- Phase-Specific Antibiotic Resistance Mechanisms in anbioRxiv : the preprint server for biology · 2025Article
- Molecular Characterization ofArchives of Razi Institute · 2025Article
- A novel multilayer antimicrobial urinary catheter material with antimicrobial properties.Materials advances · 2025Article
- Mutations in the riboflavin biosynthesis pathway confer resistance to furazolidone and abolish the synergistic interaction between furazolidone and vancomycin inMicrobial genomics · 2025Article
- Unlocking Nitrofurantoin: Understanding Molecular Mechanisms of Action and Resistance in Enterobacterales.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2025Review
- Improving nitrofurantoin resistance prediction inAntimicrobial agents and chemotherapy · 2024Article
- Regional variations in antimicrobial susceptibility of community-acquired uropathogenicIJID regions · 2024Article
- Unveiling the genetic architecture and transmission dynamics of a novel multidrug-resistant plasmid harboring blaBMC microbiology · 2024Article
- Modification of the penicillin-binding-protein 3 as a source of resistance to broad-spectrum cephalosporins in Escherichia coli.The Journal of antimicrobial chemotherapy · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 2 countries.
Yu WanNIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Imperial College London, London, United Kingdom.
Ewurabena MillsNIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Imperial College London, London, United Kingdom.
Rhoda C Y LeungNIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Imperial College London, London, United Kingdom.
Ana VieiraNIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Imperial College London, London, United Kingdom.
Xiangyun ZhiNIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Imperial College London, London, United Kingdom.
Nicholas J CroucherDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom.
Neil WoodfordAntimicrobial Resistance and Healthcare Associated Infections Reference Unit, National Infection Service, Public Health England, Colindale, London, United Kingdom.
Elita JauneikaiteNIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Imperial College London, London, United Kingdom.
Matthew J EllingtonNIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Imperial College London, London, United Kingdom.
Shiranee SriskandanNIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department of Infectious Disease, Imperial College London, London, United Kingdom.
NIHR Imperial Biomedical Research Centre · GBPublic Health England · GBImperial College London · GBQueen Mary Hospital · CN
Funding
Medical Research Council MR/R015600/1Medical Research Council MR/T016434/1Wellcome TrustWellcome Trust 104169/Z/14/A
Abstract
PubMed holds no abstract for this paper.
Indexed as
Drug Resistance, BacterialAlgorithmsEscherichia coliEscherichia coli ProteinsGene Expression Regulation, BacterialHigh-Throughput Nucleotide SequencingHumansMultienzyme ComplexesMutagenesis, InsertionalNitrofurantoinNitroreductasesSequence DeletionTranscriptional ActivationUnited KingdomUrinary Tract InfectionsWhole Genome Sequencing6,7-dimethyl-8-ribityllumazine synthaseEscherichia coli ProteinsMultienzyme ComplexesNfsA protein, E coliNfsB protein, E coliNitrofurantoinNitroreductasesantimicrobial resistancechromosomal mutationsEscherichia coliNitrofurantoinPredicting resistanceresistance mechanisms
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.